These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 35816404)
1. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology. Fracassi A; Marcatti M; Tumurbaatar B; Woltjer R; Moreno S; Taglialatela G Brain Pathol; 2023 Jan; 33(1):e13108. PubMed ID: 35816404 [TBL] [Abstract][Full Text] [Related]
2. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603 [TBL] [Abstract][Full Text] [Related]
4. Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines. Guptarak J; Scaduto P; Tumurbaatar B; Zhang WR; Jupiter D; Taglialatela G; Fracassi A Alzheimers Dement; 2024 Jul; 20(7):4677-4691. PubMed ID: 38829680 [TBL] [Abstract][Full Text] [Related]
5. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice. Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response. Cui X; Qiao J; Liu S; Wu M; Gu W Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435 [TBL] [Abstract][Full Text] [Related]
7. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice. Qu W; Li L J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402 [TBL] [Abstract][Full Text] [Related]
8. Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology. Kok FK; van Leerdam SL; de Lange ECM J Alzheimers Dis; 2022; 87(1):51-81. PubMed ID: 35275527 [TBL] [Abstract][Full Text] [Related]
9. Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2. Park JC; Han JW; Lee W; Kim J; Lee SE; Lee D; Choi H; Han J; Kang YJ; Diep YN; Cho H; Kang R; Yu WJ; Lee J; Choi M; Im SW; Kim JI; Mook-Jung I Adv Sci (Weinh); 2024 Sep; 11(34):e2400064. PubMed ID: 38981007 [TBL] [Abstract][Full Text] [Related]
11. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model. Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586 [No Abstract] [Full Text] [Related]
12. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology. Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423 [TBL] [Abstract][Full Text] [Related]
13. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the Shi Q; Chang C; Saliba A; Bhat MA J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148 [TBL] [Abstract][Full Text] [Related]
14. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z MAbs; 2022; 14(1):2107971. PubMed ID: 35921534 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746 [TBL] [Abstract][Full Text] [Related]
16. TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia. Winfree RL; Seto M; Dumitrescu L; Menon V; De Jager P; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ Acta Neuropathol; 2023 Jun; 145(6):733-747. PubMed ID: 36966244 [TBL] [Abstract][Full Text] [Related]
17. TREM2 expression in the human brain: a marker of monocyte recruitment? Fahrenhold M; Rakic S; Classey J; Brayne C; Ince PG; Nicoll JAR; Boche D; Brain Pathol; 2018 Sep; 28(5):595-602. PubMed ID: 28987033 [TBL] [Abstract][Full Text] [Related]
18. LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions. Zhao P; Xu Y; Jiang LL; Fan X; Ku Z; Li L; Liu X; Deng M; Arase H; Zhu JJ; Huang TY; Zhao Y; Zhang C; Xu H; Tong Q; Zhang N; An Z Mol Neurodegener; 2022 Jun; 17(1):44. PubMed ID: 35717259 [TBL] [Abstract][Full Text] [Related]
20. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease. Qu W; Li L Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]